SEC 13F Intelligence

Algert Global LLC / AXSM

Algert Global LLC’s Axsome Therapeutics Inc. Position

Does Algert Global LLC own Axsome Therapeutics Inc. (AXSM)? Yes — 135.5K shares worth $23M (+0.34% of its 13F portfolio) as of Q1 2026, down from 149.4K shares the prior filed quarter.

Position Value
$23M
Q1 2026
Shares
135.5K
% of Portfolio
+0.34%
Quarters Held
7
currently held

Position History AXSM

Reported value by quarter
Q3 ’22: $270,000Q3 ’22Q2 ’24: $250,000Q2 ’24Q1 ’25: $3MQ1 ’25Q2 ’25: $4MQ2 ’25Q3 ’25: $5MQ3 ’25Q4 ’25: $27MQ4 ’25Q1 ’26: $23MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026135.5K$23M+0.34%
Q4 2025149.4K$27M+0.43%
Q3 202544.1K$5M+0.09%
Q2 202537.4K$4M+0.08%
Q1 202525.9K$3M+0.07%
Q2 20243.1K$250,000+0.01%
Q3 20226.0K$270,000+0.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Algert Global LLC’s full portfolio or all institutional holders of AXSM.